Premium
Treatment of cicatricial pemphigoid with tetracycline and nicotinamide
Author(s) -
POSKITT L.,
WOJNAROWSKA F.
Publication year - 1995
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1995.tb01317.x
Subject(s) - medicine , cicatricial pemphigoid , dermatology , regimen , pemphigoid , adverse effect , tetracycline , bullous pemphigoid , nicotinamide , surgery , immunology , antibiotics , biochemistry , chemistry , biology , antibody , microbiology and biotechnology , enzyme
Summary Cicatricial pemphigoid is a rare autoimmune blistering disease involving predominantly mucosal areas in elderly patients. It runs a chronic relapsing course. Immunosuppressive treatments are frequently complicated by adverse effects and require careful monitoring. A 69‐year‐old woman is reported who responded well to a simple regimen of combined tetracycline and nicotinamide after 15 years of inadequate disease control and numerous adverse effects from immunosuppressive agents.